Artificial intelligence for precision medicine in autoimmune liver disease
Autoimmune liver diseases (AiLDs) are rare autoimmune conditions of the liver and the biliary tree with unknown etiology and limited treatment options. AiLDs are inherently characterized by a high degree of complexity, which poses great challenges in understanding their etiopathogenesis, developing...
Main Authors: | Alessio Gerussi, Miki Scaravaglio, Laura Cristoferi, Damiano Verda, Chiara Milani, Elisabetta De Bernardi, Davide Ippolito, Rosanna Asselta, Pietro Invernizzi, Jakob Nikolas Kather, Marco Carbone |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.966329/full |
Similar Items
-
Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies
by: Alessio Gerussi, et al.
Published: (2020-01-01) -
New Therapeutic Targets in Autoimmune Cholangiopathies
by: Alessio Gerussi, et al.
Published: (2020-04-01) -
New insights on the role of human leukocyte antigen complex in primary biliary cholangitis
by: Giacomo Mulinacci, et al.
Published: (2022-08-01) -
Challenges in the diagnosis and management of AIH-PBC syndrome
by: Alessio Gerussi, et al.
Published: (2025-01-01) -
Coronavirus Disease 2019 in Autoimmune Hepatitis: A Lesson From Immunosuppressed Patients
by: Alessio Gerussi, et al.
Published: (2020-09-01)